TearClear Completes $4.5MM Series A Financing co-led by Visionary Ventures
TearClear closes series A financing and introduces leadership team of accomplished ophthalmology veterans with the proceeds going to advance the development of the Company’s delivery system for preservative-free ophthalmic drugs.